Ibu and Lenticular opacities - a phase IV clinical study of FDA data

Summary:

Lenticular opacities is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are male, 50-59 old, also take Orfadin, and have Alkaptonuria.

The phase IV clinical study analyzes which people have Lenticular opacities when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.

What is Lenticular opacities?

Lenticular opacities (swelling and opacity of the entire lens) is found to be associated with 75 drugs and 152 conditions by eHealthMe. Check the latest studies of Lenticular opacities.

On Aug, 08, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 18 people (0.01%) have Lenticular opacities.

Among these 18 people:

What is the gender of people who have Lenticular opacities when taking Ibu? *

female: 47.06 %
male: 52.94 %

What is the age of people who have Lenticular opacities when taking Ibu? *

What are other drugs people take besides Ibu? *

What are other side effects people have besides Lenticular opacities? *

Amino Acid Level Increased: 15 people, 83.33%
Cataract (clouding of the lens inside the eye): 13 people, 72.22%
Conjunctival Cyst (thin-walled sac or vesicle that contains fluid in eye covering): 3 people, 16.67%
Conjunctival Oedema (conjunctival swelling): 3 people, 16.67%
Dry Eyes (lack of adequate tears): 3 people, 16.67%
Cataract Subcapsular (cataracts that affect the back of the lens): 2 people, 11.11%
Punctate Keratitis (inflammation of the cornea with tiny spots): 2 people, 11.11%
Pinguecula (slightly elevated elastic tissue deposit in the conjunctiva): 2 people, 11.11%
Melanosis (a disorder of pigmentation of the wall of the colon): 2 people, 11.11%
Visual Acuity Reduced (reduced clearness of vision): 2 people, 11.11%

What are the existing conditions these people have? *

Alkaptonuria (black urine disease): 15 people, 83.33%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 2 people, 11.11%
Type 2 Diabetes: 1 person, 5.56%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Lenticular opacities?

- Check whether Lenticular opacities is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,531 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lenticular opacities:

Lenticular opacities (75 drugs)

Browse all the conditions that are associated with Lenticular opacities:

Lenticular opacities (152 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.